Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer (Q35722781)

9 August 2017

title

Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer (English)

1 reference

9 August 2017

0 references

1 reference

Oguz Akin

3

0 references

Hedvig Hricak

object named as

Hedvig Hricak

2

0 references

Michael W Kattan

object named as

Michael W Kattan

9

0 references

Amita Shukla-Dave

1

object named as

Amita Shukla-Dave

1 reference

9 August 2017

Changhong Yu

4

1 reference

9 August 2017

Kristen L Zakian

5

1 reference

9 August 2017

Kazuma Udo

6

1 reference

9 August 2017

Peter T Scardino

7

1 reference

9 August 2017

James Eastham

8

1 reference

9 August 2017

language of work or name

1 reference

20 September 2011

1 reference

9 August 2017

1 reference

9 August 2017

volume

109

1 reference

9 August 2017

issue

9

1 reference

9 August 2017

page(s)

1315-1322

1 reference

Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Prostate MRI and 3D MR spectroscopy: how we do it

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

MR imaging of the prostate in clinical practice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression? A systematic review and meta-analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Multiparametric magnetic resonance imaging in prostate cancer: present and future

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Predicting clinical end points: treatment nomograms in prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Prospective evaluation of men with stage T1C adenocarcinoma of the prostate

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic Tests

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Correlation between visual clues, objective architectural features, and interobserver agreement in prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Histologic grading of prostate cancer: a perspective

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

12 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10612.X

Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10612.X

Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10612.X

Sampling, submission, and report format for multiple prostate biopsies: a 1999 survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10612.X

Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10612.X

Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10612.X

Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10612.X

Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10612.X

21 January 2018

What is a real nomogram?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270152

The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis

23 October 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10612.X

Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors

21 January 2018

1 reference

12 December 2020

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

12 December 2020

Fragmentation of prostatic needle biopsy cores containing adenocarcinoma: the role of specimen submission

1 reference

12 December 2020

The impact of core biopsy fragmentation in prostate cancer

1 reference

12 December 2020

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

1 reference

12 December 2020

10.1111/J.1464-410X.2011.10612.X

Identifiers

DOI

1 reference

9 August 2017

1 reference

9 August 2017

1 reference